EXPRS2.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:29):

ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark...

Stats
Today's Volume	34 344.00
Average Volume	125 702
Market Cap	140.85M
EPS	SEK-0.443 ( 2023-11-16 )
Next earnings date	( SEK0 ) 2024-05-30
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-1.040
ATR14	SEK0.0440 (1.61%)

Volume Correlation

Long: 0.05 (neutral)

Short: -0.09 (neutral)

Signal:(56.321) Neutral

ExpreS2ion Biotech Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ExpreS2ion Biotech Correlation - Currency/Commodity

0.44
( neutral )

0.37
( neutral )

0.00
( neutral )

0.30
( neutral )

-0.48
( neutral )

-0.25
( neutral )

ExpreS2ion Biotech Financials

Annual	2023
Revenue:	SEK8.80M
Gross Profit:	SEK5.15M (58.55 %)
EPS:	SEK-2.08

FY	2023
Revenue:	SEK8.80M
Gross Profit:	SEK5.15M (58.55 %)
EPS:	SEK-2.08

FY	2022
Revenue:	SEK5.09M
Gross Profit:	SEK5 000.00 (0.10 %)
EPS:	SEK-3.14

FY	2021
Revenue:	SEK12.23M
Gross Profit:	SEK4.72M (38.59 %)
EPS:	SEK-1.336

Financial Reports:

No articles found.

ExpreS2ion Biotech

ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Phase II clinical trial, as well as develops malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark.